On Oct. 1, the FDA implemented its restructuring of the Office of Regulatory Affairs (ORA) to form a new Office of Inspections and Investigations (OII), which Commissioner of Food and Drugs Dr. Robert M. Califf said would focus on inspections, investigations and imports as its core mission. Califf said that the restructuring of ORA “has an impact on how the FDA oversees all F... Read More